These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 18372525

  • 1. Release of soluble IL-6 receptor (IL-6sR) in comparison with release of soluble TNF receptors (sTNF-Rs) by PMNs and WBC derived from breast cancer patients.
    Jablonska E.
    Cancer Lett; 1997 Oct 28; 119(1):79-85. PubMed ID: 18372525
    [Abstract] [Full Text] [Related]

  • 2. The ability of human polymorphonuclear cells (PMNS) to release of soluble IL-6 receptor (IL-6sR) in response to different stimuli in vitro.
    Jabłońska E, Pietruska Z.
    Rocz Akad Med Bialymst; 1997 Oct 28; 42(1):89-98. PubMed ID: 9581468
    [Abstract] [Full Text] [Related]

  • 3. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997 Oct 28; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 4. Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment.
    Jablonska E.
    Cytokine; 1998 Jul 28; 10(7):540-3. PubMed ID: 9702418
    [Abstract] [Full Text] [Related]

  • 5. Soluble IL-6 receptor release by PMNs and PBMC in patients with oral cavity cancer.
    Jabłońska E, Piotrowski L, Grabowska Z.
    Rocz Akad Med Bialymst; 1997 Jul 28; 42(1):99-106. PubMed ID: 9581469
    [Abstract] [Full Text] [Related]

  • 6. Soluble IL-6 and TNF receptors release by polymorphonuclear and mononuclear cells in cancer patients.
    Jablonska E.
    Neoplasma; 1999 Jul 28; 46(1):35-9. PubMed ID: 10355532
    [Abstract] [Full Text] [Related]

  • 7. Changes in soluble IL-6 receptor and IL-6 production by polymorphonuclear cells and whole blood cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1998 Jul 28; 46(1):25-9. PubMed ID: 9510942
    [Abstract] [Full Text] [Related]

  • 8. Soluble TNF receptors release by polymorphonuclear cells and the serum levels in breast cancer patients before and after treatment.
    Jabłońska E, Kiluk M, Markiewicz W.
    Neoplasma; 1998 Jul 28; 45(1):17-20. PubMed ID: 9604996
    [Abstract] [Full Text] [Related]

  • 9. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
    Tinkle SS, Newman LS.
    Am J Respir Crit Care Med; 1997 Dec 28; 156(6):1884-91. PubMed ID: 9412570
    [Abstract] [Full Text] [Related]

  • 10. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with bulimia nervosa.
    Nakai Y, Hamagaki S, Takagi R, Taniguchi A, Kurimoto F.
    Clin Endocrinol (Oxf); 2000 Sep 28; 53(3):383-8. PubMed ID: 10971457
    [Abstract] [Full Text] [Related]

  • 11. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R.
    Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355
    [Abstract] [Full Text] [Related]

  • 12. Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection.
    Shibata J, Goto H, Arisawa T, Niwa Y, Hayakawa T, Nakayama A, Mori N.
    Gut; 1999 Jul 04; 45(1):24-31. PubMed ID: 10369700
    [Abstract] [Full Text] [Related]

  • 13. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 04; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 14. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
    Tsao TC, Hong Jh, Li LF, Hsieh MJ, Liao SK, Chang KS.
    Chest; 2000 Jan 04; 117(1):103-9. PubMed ID: 10631206
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J.
    Eur Cytokine Netw; 1998 Jun 04; 9(2):155-9. PubMed ID: 9681391
    [Abstract] [Full Text] [Related]

  • 16. Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion.
    Gérain J, Liénard D, Pampallona S, Baumgartner M, Rüegg C, Buurman WA, Eggermont A, Lejeune F.
    Cytokine; 1997 Dec 04; 9(12):1034-42. PubMed ID: 9417816
    [Abstract] [Full Text] [Related]

  • 17. [Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis].
    Kacprzyk F.
    Pol Arch Med Wewn; 2002 Mar 04; 107(3):215-21. PubMed ID: 12107979
    [Abstract] [Full Text] [Related]

  • 18. [Soluble TNF-alpha receptors].
    Jabłońska E.
    Postepy Hig Med Dosw; 1997 Mar 04; 51(5):567-75. PubMed ID: 9489455
    [Abstract] [Full Text] [Related]

  • 19. IL-6sR: release from MCF-7 breast cancer cells and role in regulating peripheral oestrogen synthesis.
    Singh A, Purohit A, Wang DY, Duncan LJ, Ghilchik MW, Reed MJ.
    J Endocrinol; 1995 Nov 04; 147(2):R9-12. PubMed ID: 7490545
    [Abstract] [Full Text] [Related]

  • 20. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Nov 04; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.